Here, we are going to share Dr Reddy Share Price Target 2025 to 2040 on the basis of its fundamental and technical analysis.
Dr. Reddy’s Laboratories Ltd is an important Indian pharmaceutical company that focuses on developing, manufacturing, and marketing a wide range of pharmaceuticals across the globe.
Headquartered in Hyderabad, it plays a major role in providing affordable and innovative medicines, contributing significantly to the healthcare sector both in India and internationally.
Dr Reddy Share Key Information
| Company Name | Dr. Reddy’s Laboratories Ltd |
| Headquarters | Hyderabad |
| Sectors | Pharmaceuticals & Drugs |
| Market Cap | ₹ 1,09,341.49Cr. |
| No. of Shares | 16.69 Cr. |
| Book Value | ₹1529.74 |
| Dividend Yield | 0.61% |
| ROCE | 25.52% |
| ROE | 19.54% |
| Face Value | ₹5 |
| Sales Growth | 14.86% |
| Profit Growth | 66.18% |
Dr Reddy Business Sector
Dr. Reddy’s Laboratories operates on a vertically integrated business model, which includes the following segments:
- Pharmaceutical Services and Active Ingredients (PSAI): Involves the production and sale of APIs and intermediates.
- Global Generics: Manufacturing and distribution of generic formulations.
- Proprietary Products: Developing and marketing proprietary products and new chemical entities (NCEs).
- Biosimilars: Developing and marketing biosimilar products.
Board Members
- Satish Kallam Reddy: Chairman
- Gunupati Prasad: Chairman
- Leo Puri: Director/Board Member
- Shikha Sharma: Director/Board Member
- Kodumudi P. Krishnan: Director/Board Member
- Penny Wan: Director/Board Member
- Arun M. Kumar: Director/Board Member
- Claudio Albrecht: Director/Board Member
- Alpna Seth: Director/Board Member
- Sanjiv Mehta: Director/Board Member
Dr Reddy Share Quarterly Results
| PARTICULARS | Mar 2024 | Jun 2024 |
|---|---|---|
| Net Sales | 5,104.80 | 5,841.20 |
| Total Expenditure | 3,726.20 | 3,888.20 |
| Operating Profit | 1,378.60 | 1,953 |
| Other Income | 212.70 | 217.80 |
| Interest | 5.90 | 7.10 |
| Depreciation | 246.20 | 249.80 |
| Exceptional Items | 0 | 0 |
| Profit Before Tax | 1,339.20 | 1,913.90 |
| Tax | 304.40 | 496.70 |
| Profit After Tax | 1,034.80 | 1,417.20 |
| Adjusted EPS (Rs) | 62.04 | 84.96 |
Dr Reddy Company Profits and Losses
| PARTICULARS | Mar 2023 | Mar 2024 |
|---|---|---|
| Net Sales | 16,962.50 | 19,483.80 |
| Total Expenditure | 12,747.70 | 13,557.40 |
| Operating Profit | 4,214.80 | 5,926.40 |
| Other Income | 591.30 | 862.30 |
| Interest | 16.90 | 21.80 |
| Depreciation | 923.20 | 975.60 |
| Exceptional Items | 0 | 0 |
| Profit Before Tax | 3,866 | 5,791.30 |
| Tax | 1,253.20 | 1,449.30 |
| Net Profit | 2,612.80 | 4,342 |
| Adjusted EPS (Rs.) | 156.83 | 260.31 |
Dr Reddy Share Price Target 2025-2040
| Year | Initial Target | Year-End Target |
|---|---|---|
| 2025 | ₹6761 | ₹7195 |
| 2026 | ₹7216 | ₹7748 |
| 2027 | ₹7669 | ₹8097 |
| 2028 | ₹8122 | ₹8552 |
| 2029 | ₹8574 | ₹9350 |
| 2030 | ₹9540 | ₹10550 |
| 2035 | ₹13250 | ₹14800 |
| 2040 | ₹17450 | ₹18500 |
Dr Reddy Share Price Target 2025
| Year/Month | Predicted Target |
|---|---|
| January 2025 | ₹6761 |
| February 2025 | ₹6743 |
| March 2025 | ₹6748 |
| April 2025 | ₹6896 |
| May 2025 | ₹6873 |
| June 2025 | ₹6994 |
| July 2025 | ₹7090 |
| August 2025 | ₹7100 |
| September 2025 | ₹7166 |
| October 2025 | ₹7211 |
| November 2025 | ₹7208 |
| December 2025 | ₹7195 |
Dr Reddy Share Price Target 2026
| Year/Month | Predicted Target |
|---|---|
| January 2026 | ₹7216 |
| February 2026 | ₹7196 |
| March 2026 | ₹7204 |
| April 2026 | ₹7347 |
| May 2026 | ₹7450 |
| June 2026 | ₹7542 |
| July 2026 | ₹7554 |
| August 2026 | ₹7618 |
| September 2026 | ₹7663 |
| October 2026 | ₹7665 |
| November 2026 | ₹7698 |
| December 2026 | ₹7748 |
Dr Reddy Share Price Target 2027
| Year/Month | Predicted Target |
|---|---|
| January 2027 | ₹7669 |
| February 2027 | ₹7648 |
| March 2027 | ₹7651 |
| April 2027 | ₹7802 |
| May 2027 | ₹7773 |
| June 2027 | ₹7896 |
| July 2027 | ₹7992 |
| August 2027 | ₹8008 |
| September 2027 | ₹8069 |
| October 2027 | ₹8114 |
| November 2027 | ₹8117 |
| December 2027 | ₹8097 |
Dr Reddy Share Price Target 2028
| Year/Month | Predicted Target |
|---|---|
| January 2028 | ₹8122 |
| February 2028 | ₹8100 |
| March 2028 | ₹8105 |
| April 2028 | ₹8257 |
| May 2028 | ₹8233 |
| June 2028 | ₹8253 |
| July 2028 | ₹8356 |
| August 2028 | ₹8447 |
| September 2028 | ₹8520 |
| October 2028 | ₹8571 |
| November 2028 | ₹8565 |
| December 2028 | ₹8552 |
Dr Reddy Share Price Target 2029
| Year/Month | Predicted Target |
|---|---|
| January 2029 | ₹8574 |
| February 2029 | ₹8554 |
| March 2029 | ₹8550 |
| April 2029 | ₹8710 |
| May 2029 | ₹8692 |
| June 2029 | ₹8794 |
| July 2029 | ₹8902 |
| August 2029 | ₹8914 |
| September 2029 | ₹8965 |
| October 2029 | ₹9014 |
| November 2029 | ₹9230 |
| December 2029 | ₹9350 |
Dr Reddy Share Price Target 2030
| Year/Month | Predicted Target |
|---|---|
| January 2030 | ₹9540 |
| February 2030 | ₹9630 |
| March 2030 | ₹9450 |
| April 2030 | ₹9360 |
| May 2030 | ₹9561 |
| June 2030 | ₹9703 |
| July 2030 | ₹9806 |
| August 2030 | ₹9875 |
| September 2030 | ₹9965 |
| October 2030 | ₹10152 |
| November 2030 | ₹10250 |
| December 2030 | ₹10550 |
Dr Reddy Share Price Target 2035
| Year/Month | Predicted Target |
|---|---|
| January 2035 | ₹13250 |
| April 2035 | ₹13950 |
| July 2035 | ₹14120 |
| October 2035 | ₹14250 |
| December 2035 | ₹14800 |
Dr Reddy Share Price Target 2040
| Year/Month | Predicted Target |
|---|---|
| January 2040 | ₹17450 |
| April 2040 | ₹17560 |
| July 2040 | ₹17920 |
| October 2040 | ₹18120 |
| December 2040 | ₹18500 |
Dr Reddy Shareholding Pattern
| Terms | Percentage |
|---|---|
| Promoters | 26.65% |
| FIIs | 27.68% |
| DIIs | 20.73% |
| Others | 0% |
| Public | 10.36% |
Dr Reddy Company Competitors
- Cipla
- Lupin
- Mankind Pharma
- Aurobindo Pharma
- Torrent Pharma
Bull Case of Dr Reddy (Reasons to Invest)
Strong Global Presence: The company has a significant market share in the US, Europe, and emerging markets, making it less reliant on any single market.
Robust Product Pipeline: Dr. Reddy’s has a healthy pipeline of biosimilars and proprietary products that could drive future growth.
Vertical Integration: The company’s integrated operations help in maintaining cost efficiency and quality control.
Improving Financial Metrics: Consistent improvement in return on equity (ROE) and other key financial indicators, with a ROE of 19.42% in 2024
Bear Case of Dr Reddy (Risks Involved)
Regulatory Risks: The company operates in highly regulated markets like the US and Europe, where regulatory hurdles could impact its product launches and sales.
Dependence on Few Markets: A significant portion of revenue comes from the US market, making it vulnerable to market-specific risks.
Pricing Pressure: The generics business faces intense pricing competition, impacting profitability.
Litigation Risks: The company is exposed to legal challenges and patent litigations, which could affect its financial stability.
Dr Reddy Share Price Target: FAQ
What will be the target of Dr Reddy Share for the year 2025?
By the end of the year 2025, its share price can reach ₹7195.
What will be the target of Dr Reddy Share for the year 2026?
By the end of the year 2026, its share price can reach ₹7748.
What will be the target of Dr Reddy Share for the year 2027?
By the end of the year 2027, its share price can reach ₹8097.
What will be the target of Dr Reddy Share for the year 2028?
By the end of the year 2028, its share price can reach ₹8552.
What will be the target of Dr Reddy Share for the year 2029?
By the end of the year 2029, its share price can reach ₹9350.
What will be the target of Dr Reddy Share for the year 2030?
By the end of the year 2030 its share price can reach ₹10550.
What is the Current market cap of Dr Reddy company?
At present the market cap of this company is ₹1,09,341.49 Cr.
What is the NSE symbol of Dr Reddy company?
The symbol of this company in NSE exchange is DRREDDY.
What is the BSE symbol of Dr Reddy company?
The symbol of this company in BSE exchange is 500124.
